The Novel Oncolytic Herpes Simplex Virus Type-1 (HSV-1) VC2 Promotes Long-lasting, Systemic Anti-melanoma Tumor Immune Responses and Increased Survival in an Immunocompetent B16F10-derived Mouse Melanoma Model
| Image |  |
|---|---|
| Description | scientific article published on 11 November 2020 |
| Author/s |
author: Paul J F Rider Konstantin G Kousoulas |
| Publication date | November 11, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |